Searched for: in-biosketch:true
person:segevd01
Characterizing the landscape and impact of infections following kidney transplantation
Jackson, Kyle R; Motter, Jennifer D; Bae, Sunjae; Kernodle, Amber; Long, Jane J; Werbel, William; Avery, Robin; Durand, Christine; Massie, Allan B; Desai, Niraj; Garonzik-Wang, Jacqueline; Segev, Dorry L
Infections remain a major threat to successful kidney transplantation (KT). To characterize the landscape and impact of post-KT infections in the modern era, we used United States Renal Data System (USRDS) data linked to the Scientific Registry of Transplant Recipients (SRTR) to study 141Â 661 Medicare-primary kidney transplant recipients from January 1, 1999 to December 31, 2014. Infection diagnoses were ascertained by International Classification of Diseases, Ninth Revision (ICD-9) codes. The cumulative incidence of a post-KT infection was 36.9% at 3Â months, 53.7% at 1Â year, and 78.0% at 5Â years. The most common infections were urinary tract infection (UTI; 46.8%) and pneumonia (28.2%). Five-year mortality for kidney transplant recipients who developed an infection was 24.9% vs 7.9% for those who did not, and 5-year death-censored graft failure (DCGF) was 20.6% vs 10.1% (PÂ <Â .001). This translated to a 2.22-fold higher mortality risk (adjusted hazard ratio [aHR]: 2.15 2.222.29 , PÂ <Â .001) and 1.92-fold higher DCGF risk (aHR: 1.84 1.911.98 , PÂ <Â .001) for kidney transplant recipients who developed an infection, although the magnitude of this higher risk varied across infection types (for example, 3.11-fold higher mortality risk for sepsis vs 1.62-fold for a UTI). Post-KT infections are common and substantially impact mortality and DCGF, even in the modern era. Kidney transplant recipients at high risk for infections might benefit from enhanced surveillance or follow-up to mitigate these risks.
PMID: 32506639
ISSN: 1600-6143
CID: 5126422
FRAILTY AND KIDNEY TRANSPLANTATION: A SYSTEMATIC REVIEW AND META-ANALYSIS [Meeting Abstract]
Quint, Evelien; Zogaj, Donika; Banning, Wiesje; Benjamens, Stan; Annema, Coby; Bakker, Stephan; Nieuwenhuijs-Moeke, Gertrude; Segev, Dorry; Mcadams-Demarco, Mara; Pol, Robert
ISI:000689725500292
ISSN: 0934-0874
CID: 5133212
PRE-TRANSPLANT FRAILTY IS A KEY DETERMINANT OF GLOBAL FUNCTIONAL HEALTH AFTER LIVER TRANSPLANTATION: FROM THE MULTICENTER FUNCTIONAL ASSESSMENT IN LIVER TRANSPLANTATION (FRAILT) STUDY [Meeting Abstract]
Lai, Jennifer Cindy; Shui, Amy; Rahimi, Robert S.; Ganger, Daniel R.; Verna, Elizabeth C.; Volk, Michael; Kappus, Matthew R.; Ladner, Daniela P.; Boyarsky, Brian J.; Segev, Dorry L.; Gao, Ying; Huang, Chiung-Yu; Singer, Jonathan; Duarte-Rojo, Andres
ISI:000707188004220
ISSN: 0270-9139
CID: 5133362
Ambient Air Pollution and Mortality among Older Patients Initiating Maintenance Dialysis
Feng, Yijing; Jones, Miranda R; Chu, Nadia M; Segev, Dorry L; McAdams-DeMarco, Mara
BACKGROUND:Fine particulate matter (particulate matter with diameter <2.5 µm [PM2.5]) is associated with CKD progression and may impact the health of patients living with kidney failure. While older (aged ≥65 years) adults are most vulnerable to the impact of PM2.5, it is unclear whether older patients on dialysis are at elevated risk of mortality when exposed to fine particulate matter. METHODS:Older adults initiating dialysis (2010-2016) were identified from US Renal Data System (USRDS). PM2.5 concentrations were obtained from NASA's Socioeconomic Data and Application Center (SEDAC) Global Annual PM2.5 Grids. We investigated the association between PM2.5 and all-cause mortality using Cox proportional hazard models with linear splines [knot at the current Environmental Protection Agency (EPA) National Ambient Air Quality Standard for PM2.5 of 12 μg/m3] and robust variance. RESULTS:For older dialysis patients who resided in areas with high PM2.5, a 10 μg/m3 increase in PM2.5 was associated with 1.16-fold (95% CI: 1.08-1.25) increased risk of mortality; furthermore, those who were female (aHR = 1.26, 95% CI: 1.13-1.42), Black (aHR = 1.31, 95% CI: 1.09-1.59), or had diabetes as a primary cause of kidney failure (aHR = 1.25, 95% CI: 1.13-1.38) were most vulnerable to high PM2.5. While the mortality risk associated with PM2.5 was stronger at higher levels (aHR = 1.19, 95% CI: 1.08-1.32), at lower levels (≤12 μg/m3), PM2.5 was significantly associated with mortality risk (aHR = 1.04, 95% CI: 1.00-1.07) among patients aged ≥75 years (Pslope difference = 0.006). CONCLUSIONS:Older adults initiating dialysis who resided in ZIP codes with PM2.5 levels >12 μg/m3 are at increased risk of mortality. Those aged >75 were at elevated risk even at levels below the EPA Standard for PM2.5.
PMID: 33789279
ISSN: 1421-9670
CID: 5127082
HEALTH DISPARITIES IN LIVER TRANSPLANT EVALUATION BY THE PATIENT'S NEIGHBORHOOD DEPRIVATION [Meeting Abstract]
Strauss, Alexandra T.; Hamilton, James P.; Levin, Scott; Malinsky, Daniel S.; Sidoti, Carolyn N.; Jackson, John; Segev, Dorry L.; Jain, Vedant S.; Gurakar, Ahmet; Purnell, Tanjala S.
ISI:000707188002045
ISSN: 0270-9139
CID: 5133352
When One Size Does Not Fit All: Geographically Heterogeneous Liver Distribution [Meeting Abstract]
Mankowski, M. A.; Gentry, S.; Segev, D.; Trichakis, N.
ISI:000705310103116
ISSN: 1600-6135
CID: 5486632
ARTIFICIAL INTELLIGENCE: THE NEWEST MEMBER OF THE LIVER TRANSPLANT EVALUATION TEAM? [Meeting Abstract]
Strauss, Alexandra T.; Sidoti, Carolyn N.; Jain, Vedant S.; Sung, Hannah C.; Purnell, Tanjala S.; Gurses, Ayse; Gurakar, Ahmet; Jackson, John; Levan, Macey L.; Gray, Stephen H.; Hamilton, James P.; Segev, Dorry L.; Wang, Jacqueline G.; Hinson, Jeremiah; Malinsky, Daniel S.; Levin, Scott
ISI:000707188002017
ISSN: 0270-9139
CID: 5133342
DYNAMIC PREDICTION OF KIDNEY GRAFT SURVIVAL WITH ARTIFICIAL INTELLIGENCE: AN INTERNATIONAL STUDY OF DEEP COHORTS OF KIDNEY RECIPIENTS [Meeting Abstract]
Raynaud, Marc; Aubert, Olivier; Reese, Peter; Kamar, Nassim; Chin, Chen-Shan; Bailly, Elodie; Ladriere, Marc; Le Quintrec, Moglie; Delahousse, Michel; Juric, Ivana; Basic-Jukic, Nikolina; Crespo, Marta; Silva Junior, Helio Tedesco; Linhares, Kamilla; de Castro, Maria Cristina Ribeiro; Gervacio, Soler Pujol; Yoo, Daniel; Empana, Jean-Philippe; Ulloa, Camilo; Akalin, Enver; Boehmig, Georg; Huang, Edmund; Glotz, Denis; Jordan, Stanley; Bentall, Andrew; Montgomery, Robert; Oberbauer, Rainer; Segev, Dorry; Friedewald, John; Legendre, Christophe; Jouven, Xavier; Lefaucheur, Carmen; Loupy, Alexandre
ISI:000689725500008
ISSN: 0934-0874
CID: 5133202
Safety of the first dose of mRNA SARS-CoV-2 vaccines in patients with rheumatic and musculoskeletal diseases [Letter]
Connolly, Caoilfhionn M.; Ruddy, Jake A.; Boyarsky, Brian J.; Avery, Robin K.; Werbel, William A.; Segev, Dorry L.; Garonzik-Wang, Jacqueline; Paik, Julie J.
ISI:000675434700039
ISSN: 0003-4967
CID: 5133122
TACKLING PERSISTENT HEALTH DISPARITIES IN THE LIVER TRANSPLANT EVALUATION PROCESS: A MULTI-CENTER ANALYSIS OF PROVIDER PERSPECTIVES ON MECHANISMS AND OPPORTUNITIES TO ADVANCE EQUITY [Meeting Abstract]
Strauss, Alexandra T.; Sidoti, Carolyn N.; Jain, Vedant S.; Sung, Hannah C.; Gurses, Ayse; Jackson, John; Levan, Macey L.; Levin, Scott; Gray, Stephen H.; Segev, Dorry L.; Gurakar, Ahmet; Wang, Jacqueline G.; Hamilton, James P.; Purnell, Tanjala S.
ISI:000707188000179
ISSN: 0270-9139
CID: 5133332